| Implications of interprofessional primary care team characteristics for health services and patient health outcomes: a systematic review with narrative synthesis WD Wranik, S Price, SM Haydt, J Edwards, K Hatfield, J Weir, N Doria Health Policy 123 (6), 550-563, 2019 | 100 | 2019 |
| Healthcare policy tools as determinants of health-system efficiency: evidence from the OECD D Wranik Health Economics, Policy and Law 7 (2), 197-226, 2012 | 95 | 2012 |
| Physician remuneration methods for family physicians in Canada: expected outcomes and lessons learned DW Wranik, M Durier-Copp Health Care Analysis 18, 35-59, 2010 | 90 | 2010 |
| The relative importance of clinical, economic, patient values and feasibility criteria in cancer drug reimbursement in Canada: a revealed preferences analysis of … C Skedgel, D Wranik, M Hu Pharmacoeconomics 36, 467-475, 2018 | 48 | 2018 |
| Health human resource planning in Canada: a typology and its application D Wranik Health Policy 86 (1), 27-41, 2008 | 44 | 2008 |
| Physician payment methods: a focus on quality and cost control L Rudmik, D Wranik, C Rudisill-Michaelsen Journal of Otolaryngology-Head & Neck Surgery 43 (1), 34, 2014 | 43 | 2014 |
| Funding and remuneration of interdisciplinary primary care teams in Canada: a conceptual framework and application WD Wranik, SM Haydt, A Katz, AR Levy, M Korchagina, JM Edwards, ... BMC health services research 17, 1-12, 2017 | 33 | 2017 |
| Choice of treatment with antidepressants: influencing factors H Himmerich, D W Wranik Current pharmaceutical design 18 (36), 5958-5975, 2012 | 32 | 2012 |
| Framework for the design of physician remuneration methods in primary health care D Wranik, M Durier-Copp Social work in public health 26 (3), 231-259, 2011 | 31 | 2011 |
| Funding models and medical dominance in interdisciplinary primary care teams: qualitative evidence from three Canadian provinces WD Wranik, SM Haydt Human Resources for Health 16, 1-9, 2018 | 19 | 2018 |
| How best to structure interdisciplinary primary care teams: the study protocol for a systematic review with narrative framework synthesis WD Wranik, JA Hayden, S Price, RMN Parker, SM Haydt, JM Edwards, ... Systematic Reviews 5, 1-7, 2016 | 11 | 2016 |
| Uncertainty tolerance among experts involved in drug reimbursement recommendations: Qualitative evidence from HTA committees in Canada and Poland WD Wranik, L Gambold, S Peacock Health Policy 125 (3), 307-319, 2021 | 10 | 2021 |
| Ranking the criteria used in the appraisal of drugs for reimbursement: a stated preferences elicitation with health technology assessment stakeholders across jurisdictional … WD Wranik, M Jakubczyk, K Drachal Value in Health 23 (4), 471-480, 2020 | 10 | 2020 |
| Costs of productivity loss due to occupational cancer in Canada: estimation using claims data from Workers’ Compensation Boards WD Wranik, A Muir, M Hu Health Economics Review 7, 1-11, 2017 | 8 | 2017 |
| Threats to the value of health technology assessment: Qualitative evidence from Canada and Poland WD Wranik, DA Zielińska, L Gambold, S Sevgur Health Policy 123 (2), 191-202, 2019 | 7 | 2019 |
| The evolution of the cancer formulary review in Canada: Can centralization improve the use of economic evaluation? WD Wranik, L Gambold, N Hanson, A Levy The International Journal of Health Planning and Management 32 (2), e232-e260, 2017 | 6 | 2017 |
| Using economic evidence as a support tool for policy decisions: Herculean or Sisyphean effort? D Wranik Expert Review of Pharmacoeconomics & Outcomes Research 8 (4), 329-332, 2008 | 6 | 2008 |
| How best to pay interdisciplinary primary care teams? Funding and remuneration, a framework and typology D Wranik, M Korchagina, J Edwards, I Bower, A Levy, A Katz Dalhousie University, 2015 | 5 | 2015 |
| Barriers and solutions to implementation strategies to improve health human resource models in Canada M Durier-Copp, D Wranik Health Services Restructuring in Canada: New Evidence and New Diections, 213-244, 2007 | 5 | 2007 |
| Drug attributes associated with the selection of drugs for reimbursement: a pilot stated preferences experiment with Canadian stakeholders WD Wranik, C Skedgel, M Hu Expert Review of Pharmacoeconomics & Outcomes Research 19 (1), 59-69, 2019 | 4 | 2019 |
Susan HaydtResearch Grants Facilitator and Adjunct, Dalhousie UniversityVerified email at dal.ca
